Back
Adagene, Inc. 10K Form
Sell
27
ADAG
Adagene, Inc.
Last Price:
$1.95
Seasonality Move:
-6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADAG News And Ratings
See the #1 stock for the next 7 days that we like better than ADAG
ADAG Financial Statistics
Sales & Book Value
| Annual Sales: | $103.3K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.07 |
| Price / Book: | 1.78 |
Profitability
| EPS (TTM): | -0.63730 |
|---|---|
| Net Income (TTM): | $-29.9M |
| Gross Margin: | $-823.5K |
| Return on Equity: | -56.44% |
| Return on Assets: | -32.79% |
Adagene, Inc. Earnings Forecast
Key Adagene, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ADAG is -797.19%.
-
The Selling, General & Administrative Expenses for ADAG have been equal to 7,044.53% of Gross Profit Margin.
-
The Research & Development expenses have been 26,978.80% of Revenue.
-
The Net Earning history of ADAG is -32,372.60% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Adagene, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADAG |
| Website: | adagene.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 2.3 |
| Quick Ratio: | 2.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ADAG Technical Analysis vs Fundamental Analysis
Sell
27
Adagene, Inc. (ADAG)
is a Sell
Is Adagene, Inc. a Buy or a Sell?
-
Adagene, Inc. stock is rated a SellThe current Adagene, Inc. [ADAG] share price is $1.97. The Score for ADAG is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.